Frontier Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-9,795
Closed -$1.59M 343
2015
Q4
$1.59M Sell
9,795
-2,369
-19% -$372K 0.01% 304
2015
Q3
$1.68M Sell
12,164
-3,803
-24% -$599K 0.01% 305
2015
Q2
$2.45M Hold
15,967
0.02% 307
2015
Q1
$2.55M Sell
15,967
-16,715
-51% -$2.63M 0.02% 307
2014
Q4
$5.21M Buy
32,682
+775
+2% +$121K 0.04% 293
2014
Q3
$4.48M Buy
31,907
+400
+1% +$52.2K 0.04% 285
2014
Q2
$3.73M Sell
31,507
-3,945
-11% -$457K 0.03% 290
2014
Q1
$4.37M Buy
35,452
+1,342
+4% +$163K 0.03% 298
2013
Q4
$3.89M Buy
+34,110
New +$3.88M 0.03% 290

Other funds holding AMGN

Frontier Capital Management's AMGN Position: Q1 2016 in Review

Frontier Capital Management sold out of Amgen (AMGN) in Q1 2016, closing a stake of 9,795 shares — an estimated $1.59M sold.

Frontier Capital Management first reported a position in AMGN in Q4 2013 and held it in 9 quarters. The position peaked at $5.21M in Q4 2014. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Frontier Capital Management reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Frontier Capital Management sold 9,795 Amgen shares in Q1 2016, an estimated $1.59M.
  • Frontier Capital Management first reported a position in Amgen in Q4 2013 and held it in 9 quarters.
  • Frontier Capital Management's Amgen position peaked at $5.21M in Q4 2014.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Frontier Capital Management's 13F filing for Q1 2016, filed 4 May 2016.